200+ Free BCACP Practice Questions

Pass your Board Certified Ambulatory Care Pharmacist exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

68-72% Pass Rate

200+ Questions

100% Free

1 / 200

Question 1

Score: 0/0

A 58-year-old patient with type 2 diabetes (HbA1c 8.2%, eGFR 45 mL/min/1.73m²) is currently on metformin 1000 mg twice daily. Which is the most appropriate next step according to the 2024 ADA Standards of Care?

Add glipizide 5 mg daily

Add empagliflozin 10 mg daily

Increase metformin to 2000 mg twice daily

Add sitagliptin 100 mg daily

to track

2026 Statistics

Key Facts: BCACP Exam

175

Total Questions

150 scored

3h 30m

Exam Time

BCACP format

500/800

Passing Score

Scaled scoring

37%

Pharmacotherapy

Largest domain

$600

Exam Fee

BPS 2026

7 years

Certification Valid

Recertification cycle

The BCACP exam has a pass rate of approximately 68-72%. The exam uses 175 questions over 3 hours 30 minutes with scaled scoring (200-800, 500 passing). Content covers diabetes, hypertension, dyslipidemia, anticoagulation, heart failure, COPD/asthma, CKD, mental health, pain management, immunizations, MTM services, and evidence-based medicine. BCACP certification requires recertification every 7 years. Eligibility requires PharmD + active license + 3 years ambulatory care practice or PGY2 ambulatory care residency within 7 years.

Sample BCACP Practice Questions

Try these sample questions to test your BCACP exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 200+ question experience with AI tutoring.

1A 58-year-old patient with type 2 diabetes (HbA1c 8.2%, eGFR 45 mL/min/1.73m²) is currently on metformin 1000 mg twice daily. Which is the most appropriate next step according to the 2024 ADA Standards of Care?

A.Add glipizide 5 mg daily

B.Add empagliflozin 10 mg daily

C.Increase metformin to 2000 mg twice daily

D.Add sitagliptin 100 mg daily

Explanation: Per 2024 ADA guidelines, for patients with T2DM and CKD (eGFR ≥20 mL/min/1.73m²), an SGLT2 inhibitor with proven cardiovascular or kidney benefits (empagliflozin, dapagliflozin, or canagliflozin) is recommended to reduce progression of CKD and cardiovascular events. Glipizide is not preferred due to hypoglycemia risk. Metformin should be reduced when eGFR <45.

2Which of the following is the preferred first-line agent for hypertension in a patient with diabetes and albuminuria (UACR 350 mg/g)?

A.Amlodipine 5 mg daily

B.Lisinopril 10 mg daily

C.Hydrochlorothiazide 25 mg daily

D.Metoprolol succinate 50 mg daily

Explanation: Per ADA and KDIGO guidelines, ACE inhibitors (like lisinopril) or ARBs are first-line for hypertension in patients with diabetes and albuminuria (UACR ≥300 mg/g) due to proven renal protection benefits. They reduce progression of diabetic kidney disease and cardiovascular events in this population.

3A 65-year-old patient with HFrEF (LVEF 35%) is on lisinopril 20 mg daily and metoprolol succinate 50 mg daily. Which medication should be added next per GDMT guidelines?

A.Digoxin 0.125 mg daily

B.Spironolactone 25 mg daily

C.Hydralazine-isosorbide dinitrate

D.Ivabradine 5 mg twice daily

Explanation: Per 2022 AHA/ACC/HFSA guidelines, the four pillars of HFrEF GDMT are: 1) ACEi/ARB/ARNI, 2) Evidence-based beta-blocker, 3) MRA (spironolactone or eplerenone), and 4) SGLT2 inhibitor. Since the patient is already on ACEi and beta-blocker, adding an MRA is the next step. MRAs reduce mortality and hospitalization in HFrEF.

4Which statin intensity is appropriate for a 60-year-old patient with ASCVD (prior MI) to achieve LDL reduction goals?

A.Low-intensity (e.g., simvastatin 10 mg)

B.Moderate-intensity (e.g., atorvastatin 20 mg)

C.High-intensity (e.g., atorvastatin 40-80 mg)

D.Very-high intensity (e.g., atorvastatin 80 mg + ezetimibe)

Explanation: Per 2018 AHA/ACC cholesterol guidelines, patients with clinical ASCVD (prior MI, stroke, or symptomatic PAD) should receive high-intensity statin therapy (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) to achieve ≥50% LDL reduction. The goal is LDL <100 mg/dL or ≥50% reduction if baseline is unknown.

5A patient with non-valvular atrial fibrillation (CHA₂DS₂-VASc score 4) and normal renal function should be initiated on which anticoagulant?

A.Aspirin 81 mg daily

B.Warfarin with INR goal 2.0-3.0

C.Apixaban 5 mg twice daily

D.Rivaroxaban 15 mg daily

Explanation: Per 2023 ACC/AHA/ACCP/HRS guidelines, DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) are preferred over warfarin for non-valvular AF (excluding moderate-severe mitral stenosis or mechanical valves). Apixaban has the best safety profile with lowest bleeding risk. Aspirin alone is not recommended for stroke prevention in AF.

6A patient with COPD (FEV₁ 55% predicted, 2 exacerbations in past year) is on albuterol PRN. Which is the next step per GOLD 2024 guidelines?

A.Add tiotropium (LAMA) daily

B.Add fluticasone-salmeterol (ICS/LABA)

C.Start roflumilast

D.Add montelukast

Explanation: Per GOLD 2024, for patients with COPD Group B (few symptoms) or Group E (exacerbator) not on maintenance therapy, a LAMA (long-acting muscarinic antagonist) is the preferred first maintenance treatment. Tiotropium reduces exacerbations and improves symptoms. ICS/LABA is reserved for patients with higher eosinophils or frequent exacerbations despite LAMA.

7A patient with hypothyroidism has been stable on levothyroxine 100 mcg daily with TSH 3.8 mIU/L. When should TSH be rechecked?

A.In 4 weeks

B.In 6 weeks

C.In 6 months

D.In 12 months

Explanation: Per ATA guidelines, once a patient is stable on levothyroxine (TSH within normal limits), TSH should be monitored every 6-12 months or sooner if clinically indicated. Stable patients do not need frequent monitoring. TSH takes 4-6 weeks to reach steady state after dose changes, which is when testing is done after adjustments.

8Which antidepressant would be preferred for a patient with major depressive disorder and comorbid insomnia?

A.Fluoxetine 20 mg daily

B.Sertraline 50 mg daily

C.Mirtazapine 15 mg at bedtime

D.Venlafaxine XR 75 mg daily

Explanation: Mirtazapine has sedating properties due to its H1 antagonism and is often preferred for patients with depression and insomnia. It is typically dosed at bedtime and can help with both conditions. SSRIs like fluoxetine and sertraline may cause insomnia in some patients.

9A patient with osteoarthritis has inadequate pain control with acetaminophen 3 g/day. Which is the next appropriate step?

A.Add ibuprofen 800 mg three times daily

B.Add tramadol 50 mg twice daily

C.Switch to naproxen 500 mg twice daily

D.Add topical diclofenac gel

Explanation: Per ACR/Arthritis Foundation 2022 guidelines, topical NSAIDs (diclofenac gel) are preferred over oral NSAIDs for knee and hand OA when acetaminophen is inadequate, due to lower systemic absorption and reduced GI/renal/cardiovascular risks. Oral NSAIDs should be used at the lowest effective dose for the shortest duration.

10Which vaccines are recommended for all adults aged 65 years and older?

A.Influenza, Pneumococcal (PCV20 or PCV15+PPSV23), COVID-19, and Tdap

B.Influenza and Pneumococcal only

C.Influenza, COVID-19, and Shingrix only

D.All vaccines are optional for this age group

Explanation: Per CDC ACIP 2024 recommendations, all adults ≥65 years should receive: annual influenza, pneumococcal (either PCV20 once or PCV15 followed by PPSV23), updated COVID-19 vaccine, and one dose of Tdap (then Td or Tdap booster every 10 years). Shingrix (shingles) is also recommended for immunocompetent adults ≥50 years.

About the BCACP Exam

The BCACP certification is a specialized credential for pharmacists practicing in ambulatory care settings. The exam covers 4 domains: Patient-Centered Care: Ambulatory Care Pharmacotherapy (37%), Patient-Centered Care: Collaboration and Communication, Translation of Evidence into Practice (~15%), and Practice Advancement (~10%). The exam consists of 175 items (150 scored, 25 unscored) over 3 hours 30 minutes.

Questions

175 scored questions

Time Limit

3 hours 30 minutes

Passing Score

500/800 (scaled)

Exam Fee

$600 (Board of Pharmacy Specialties (BPS))

BCACP Exam Content Outline

37%

Patient-Centered Care: Ambulatory Care Pharmacotherapy

Diabetes management (metformin, GLP-1, SGLT2, insulin), hypertension (ACEi/ARB, CCB, thiazides), dyslipidemia (statins, ezetimibe, PCSK9), anticoagulation (warfarin, DOACs), COPD/asthma (inhalers, biologics), heart failure GDMT (ARNI, beta-blockers, MRA, SGLT2), CKD management, mental health pharmacotherapy, pain management, immunizations, and OTC therapy management

~28%

Patient-Centered Care: Collaboration and Communication

Interprofessional collaboration, patient education and counseling, health literacy, cultural competency, shared decision-making, telehealth practice, care coordination, transitions of care, patient advocacy, MTM services, medication reconciliation, and social determinants of health

~15%

Translation of Evidence into Practice

Evidence-based medicine principles, clinical practice guidelines (ADA, AHA/ACC, GOLD, GINA), literature evaluation, research appraisal, quality improvement methodologies, outcome measures, formulary management, and pharmacoeconomics

~10%

Practice Advancement

Pharmacy operations, regulatory compliance, documentation requirements, HIPAA and privacy, quality assurance, scope of practice, precepting and mentorship, and professional development

How to Pass the BCACP Exam

What You Need to Know

Passing score: 500/800 (scaled)
Exam length: 175 questions
Time limit: 3 hours 30 minutes
Exam fee: $600

Keys to Passing

Complete 500+ practice questions
Score 80%+ consistently before scheduling
Focus on highest-weighted sections
Use our AI tutor for tough concepts

BCACP Study Tips from Top Performers

1Master diabetes management - know ADA guidelines, A1C targets, medication selection by comorbidity (ASCVD, HF, CKD), and insulin dosing

2Understand hypertension treatment - JNC-8 and ACC/AHA guidelines, first-line agents, combination therapy, and resistant hypertension

3Know heart failure GDMT - ARNI/ACEi/ARB, evidence-based beta-blockers, MRAs, and SGLT2 inhibitors with titration strategies

4Study anticoagulation - warfarin dosing/monitoring, DOAC selection by indication, reversal agents, and peri-procedural management

5Review ambulatory COPD/asthma - inhaler technique, step therapy, biologic selection, and exacerbation prevention

Frequently Asked Questions

What is the BCACP pass rate?

The BCACP pass rate typically ranges from 68-72% depending on preparation and experience. The exam uses scaled scoring from 200-800, with 500 required to pass. The exam covers a broad range of ambulatory care topics requiring both clinical knowledge and collaborative practice skills.

How many questions are on the BCACP exam?

The BCACP exam contains 175 questions total, with 150 scored and 25 unscored pretest questions. You have 3 hours and 30 minutes to complete the exam. The exam covers 4 domains: Pharmacotherapy (37%), Collaboration (~28%), Evidence Translation (~15%), and Practice Advancement (~10%).

What are the BCACP eligibility requirements?

To sit for the BCACP exam, you must have: (1) Graduated from an ACPE-accredited PharmD program, (2) Current, active pharmacist license, and (3) Either 3 years of ambulatory care pharmacy practice OR completion of PGY2 ambulatory care residency within the past 7 years.

How long is BCACP certification valid?

BCACP certification is valid for 7 years. Recertification can be achieved by either passing the exam again OR completing 100 hours of ambulatory care-specific continuing education through BPS-approved programming.

What are the best study resources for BCACP?

Recommended BCACP study resources include: ADA Standards of Care, AHA/ACC guidelines, GOLD/GINA guidelines, ACCP Ambulatory Care Guidelines, Pharmacotherapy: A Pathophysiologic Approach (DiPiro), and ambulatory care pharmacotherapy review courses. Plan for 3-4 months of study time. Focus on high-yield topics like diabetes, hypertension, heart failure, and anticoagulation.

How should I prepare for the BCACP exam?

Study systematically across all domains: Pharmacotherapy (37%), Collaboration (~28%), Evidence Translation (~15%), and Practice Advancement (~10%). Focus on clinical scenarios, medication therapy management, and guideline-based care. Complete at least 2000 practice questions covering diabetes, hypertension, dyslipidemia, anticoagulation, heart failure, and COPD/asthma.